Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study.
Pérez de Isla L, Arroyo-Olivares R, Muñiz-Grijalvo O, Diaz-Díaz JL, Zambón D, Fuentes F, Sánchez Muñoz-Torrero JF, Mediavilla JD, González-Estrada A, Miramontes-González JP, de Andrés R, Mauri M, Mosquera D, Cepeda JM, Suárez L, Barba-Romero MÁ, Argüeso R, Álvarez-Baños P, Michán A, Romero-Jiménez MJ, García-Cruces J, Padró T, Alonso R, Mata P. Pérez de Isla L, et al. J Clin Lipidol. 2019 Nov-Dec;13(6):989-996. doi: 10.1016/j.jacl.2019.10.005. Epub 2019 Oct 11. J Clin Lipidol. 2019. PMID: 31706904 Free article.
[Combined treatment: regimens, indications and safety profile].
Muñiz Grijalvo O, Villar Ortiz J. Muñiz Grijalvo O, et al. Clin Investig Arterioscler. 2013 Jul-Aug;25(3):140-5. doi: 10.1016/j.arteri.2013.06.003. Epub 2013 Jul 21. Clin Investig Arterioscler. 2013. PMID: 23880257 Spanish.
Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study.
Pérez de Isla L, Alonso R, Muñiz-Grijalvo O, Díaz-Díaz JL, Zambón D, Miramontes JP, Fuentes F, Gómez de Diego JJ, González-Estrada A, Mata N, Saltijeral A, Barreiro M, Tomás M, de Andrés R, Argüeso R, Serrano Gotarredona MP, Navarro Herrero S, Perea Palazón RJ, de Caralt TM, Suárez de Centi LA, Zhilina S, Espejo Pérez S, Padró T, Mata P; SAFEHEART investigators. Pérez de Isla L, et al. J Clin Lipidol. 2018 Jul-Aug;12(4):948-957. doi: 10.1016/j.jacl.2018.04.003. Epub 2018 Apr 17. J Clin Lipidol. 2018. PMID: 29753733
Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society.
Ariza MJ, Rioja J, Ibarretxe D, Camacho A, Díaz-Díaz JL, Mangas A, Carbayo-Herencia JA, Ruiz-Ocaña P, Lamíquiz-Moneo I, Mosquera D, Sáenz P, Masana L, Muñiz-Grijalvo O, Pérez-Calahorra S, Valdivielso P; Spanish Dyslipidemia Registry. Ariza MJ, et al. J Clin Lipidol. 2018 Nov-Dec;12(6):1482-1492.e3. doi: 10.1016/j.jacl.2018.07.013. Epub 2018 Aug 1. J Clin Lipidol. 2018. PMID: 30150141
Familial Hypercholesterolaemia Diagnosis and Management.
Alonso R, Perez de Isla L, Muñiz-Grijalvo O, Diaz-Diaz JL, Mata P. Alonso R, et al. Eur Cardiol. 2018 Aug;13(1):14-20. doi: 10.15420/ecr.2018:10:2. Eur Cardiol. 2018. PMID: 30310464 Free PMC article. Review.
Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study.
Blom DJ, O'Dea L, Digenio A, Alexander VJ, Karwatowska-Prokopczuk E, Williams KR, Hemphill L, Muñiz-Grijalvo O, Santos RD, Baum S, Witztum JL. Blom DJ, et al. J Clin Lipidol. 2018 Sep-Oct;12(5):1234-1243.e5. doi: 10.1016/j.jacl.2018.05.013. Epub 2018 May 31. J Clin Lipidol. 2018. PMID: 30318066 Free article. Clinical Trial.
Adults with familial hypercholesterolaemia have healthier dietary and lifestyle habits compared with their non-affected relatives: the SAFEHEART study.
Arroyo-Olivares R, Alonso R, Quintana-Navarro G, Fuentes-Jiménez F, Mata N, Muñiz-Grijalvo O, Díaz-Díaz JL, Zambón D, Arrieta F, García-Cruces J, Garrido-Sanjuan JA, Banegas JR, Mata P. Arroyo-Olivares R, et al. Public Health Nutr. 2019 Jun;22(8):1433-1443. doi: 10.1017/S1368980018003853. Epub 2019 Feb 8. Public Health Nutr. 2019. PMID: 30732662 Free PMC article.
VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia.
Miramontes-González JP, Usategui-Martín R, Pérez de Isla L, Alonso R, Muñiz-Grijalvo O, Díaz-Díaz JL, Zambón D, Jiménez FF, Martín-Vallejo J, Rodríguez Gude AE, Jiménez DL, Padro T, González-Sarmiento R, Mata P. Miramontes-González JP, et al. Atherosclerosis. 2019 Jun;285:17-22. doi: 10.1016/j.atherosclerosis.2019.03.019. Epub 2019 Mar 31. Atherosclerosis. 2019. PMID: 30991288
Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia.
Pérez de Isla L, Ray KK, Watts GF, Santos RD, Alonso R, Muñiz-Grijalvo O, Diaz-Diaz JL, Badimon L, Catapano AL, Mata P. Pérez de Isla L, et al. Atherosclerosis. 2019 Jul;286:40-45. doi: 10.1016/j.atherosclerosis.2019.05.003. Epub 2019 May 4. Atherosclerosis. 2019. PMID: 31100618 Free article.
Association of dietary components with dyslipidemia and low-grade inflammation biomarkers in adults with heterozygous familial hypercholesterolemia from different countries.
Antoniazzi L, Arroyo-Olivares R, Bittencourt MS, Tada MT, Lima I, Jannes CE, Krieger JE, Pereira AC, Quintana-Navarro G, Muñiz-Grijalvo O, Díaz-Díaz JL, Zambón D, Mata P, Santos RD. Antoniazzi L, et al. Eur J Clin Nutr. 2019 Dec;73(12):1622-1625. doi: 10.1038/s41430-019-0529-3. Epub 2019 Nov 6. Eur J Clin Nutr. 2019. PMID: 31695140
63 results